Arvind Kush - 21 Oct 2024 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Milton H. Werner, attorney-in-fact
Issuer symbol
IKT
Transactions as of
21 Oct 2024
Net transactions value
+$198,650
Form type
4
Filing time
23 Oct 2024, 19:49:49 UTC
Previous filing
27 Feb 2024
Next filing
19 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKT Common Stock Purchase $198,650 +145,000 $1.37 145,000 21 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 21 Oct 2024 Common Stock 60,000 $2.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares vest 50% on each of the first two anniversaries of October 21, 2024.